Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 7 | 2018 | 794 | 0.830 |
Why?
|
| MicroRNAs | 5 | 2022 | 386 | 0.810 |
Why?
|
| Transcription Factors | 4 | 2018 | 653 | 0.670 |
Why?
|
| Cell Movement | 3 | 2016 | 545 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2022 | 781 | 0.560 |
Why?
|
| Kidney | 3 | 2014 | 322 | 0.440 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 26 | 0.380 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 54 | 0.370 |
Why?
|
| Glycoproteins | 2 | 2011 | 100 | 0.340 |
Why?
|
| Mucin-1 | 2 | 2004 | 8 | 0.310 |
Why?
|
| Cell Proliferation | 6 | 2018 | 1149 | 0.290 |
Why?
|
| Phosphotyrosine | 1 | 2004 | 24 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 247 | 0.250 |
Why?
|
| Antigens | 1 | 2004 | 56 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 122 | 0.240 |
Why?
|
| Tyrosine | 1 | 2003 | 109 | 0.230 |
Why?
|
| Apoptosis | 4 | 2016 | 1317 | 0.220 |
Why?
|
| Mesoderm | 2 | 2014 | 70 | 0.220 |
Why?
|
| Cell Nucleus | 2 | 2014 | 351 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 80 | 0.200 |
Why?
|
| Wnt Proteins | 2 | 2011 | 20 | 0.200 |
Why?
|
| RNA, Messenger | 4 | 2022 | 1152 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2010 | 65 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 605 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 71 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1426 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2016 | 392 | 0.150 |
Why?
|
| Humans | 15 | 2022 | 34853 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 484 | 0.140 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 550 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2018 | 2128 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2016 | 209 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 480 | 0.130 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 32 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2013 | 878 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2010 | 184 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 99 | 0.120 |
Why?
|
| Antibodies | 2 | 2004 | 135 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 164 | 0.110 |
Why?
|
| Male | 8 | 2018 | 18870 | 0.110 |
Why?
|
| Telomerase | 1 | 2011 | 40 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2011 | 116 | 0.100 |
Why?
|
| Nuclear Lamina | 1 | 2010 | 1 | 0.100 |
Why?
|
| Progeria | 1 | 2010 | 9 | 0.100 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 3 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2014 | 1802 | 0.100 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 10 | 0.100 |
Why?
|
| Nephrons | 1 | 2011 | 22 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 2010 | 73 | 0.100 |
Why?
|
| Casein Kinase II | 1 | 2010 | 15 | 0.100 |
Why?
|
| Proline Oxidase | 1 | 2010 | 11 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2011 | 562 | 0.100 |
Why?
|
| Cell Line | 2 | 2004 | 1289 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 111 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 139 | 0.090 |
Why?
|
| RNA Interference | 1 | 2010 | 225 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2009 | 4 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2010 | 235 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 47 | 0.080 |
Why?
|
| Peptides | 1 | 2011 | 308 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2008 | 76 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2011 | 423 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 642 | 0.080 |
Why?
|
| Aged | 3 | 2014 | 6448 | 0.070 |
Why?
|
| Animals | 7 | 2018 | 14307 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 528 | 0.070 |
Why?
|
| Epidermal Growth Factor | 2 | 2018 | 63 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2333 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 114 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 211 | 0.070 |
Why?
|
| Mucins | 1 | 2004 | 33 | 0.060 |
Why?
|
| Middle Aged | 3 | 2014 | 9642 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 756 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 56 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 600 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 168 | 0.060 |
Why?
|
| Cadherins | 2 | 2014 | 82 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 162 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 286 | 0.060 |
Why?
|
| Mice | 4 | 2018 | 5668 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 286 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 4012 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 302 | 0.050 |
Why?
|
| Gene Expression | 2 | 2014 | 639 | 0.050 |
Why?
|
| Adult | 2 | 2014 | 11034 | 0.050 |
Why?
|
| Neoplasms | 1 | 2008 | 1033 | 0.040 |
Why?
|
| Quinazolines | 1 | 2018 | 31 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 143 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2010 | 834 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 323 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1442 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2018 | 301 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2014 | 44 | 0.030 |
Why?
|
| Female | 3 | 2022 | 19873 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 63 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 72 | 0.030 |
Why?
|
| Rats | 2 | 2011 | 3261 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 161 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2011 | 14 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 383 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 87 | 0.030 |
Why?
|
| Chromatin | 1 | 2013 | 164 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2011 | 143 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 650 | 0.030 |
Why?
|
| Cell Separation | 1 | 2011 | 91 | 0.030 |
Why?
|
| Ionomycin | 1 | 2011 | 9 | 0.030 |
Why?
|
| TCF Transcription Factors | 1 | 2011 | 14 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 352 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2011 | 48 | 0.020 |
Why?
|
| Lamin Type A | 1 | 2010 | 13 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 74 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2011 | 28 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 46 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 72 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 391 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 132 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 62 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 95 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 580 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 67 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 152 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 298 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 2 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2009 | 13 | 0.020 |
Why?
|
| Breeding | 1 | 2009 | 21 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2009 | 132 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 13 | 0.020 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 19 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 445 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 252 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 283 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 932 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 420 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 109 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 897 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 200 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 1023 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1534 | 0.020 |
Why?
|